BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1030 related articles for article (PubMed ID: 22535748)

  • 1. Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance.
    Jørgensen NB; Jacobsen SH; Dirksen C; Bojsen-Møller KN; Naver L; Hvolris L; Clausen TR; Wulff BS; Worm D; Lindqvist Hansen D; Madsbad S; Holst JJ
    Am J Physiol Endocrinol Metab; 2012 Jul; 303(1):E122-31. PubMed ID: 22535748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass.
    Bojsen-Møller KN
    Dan Med J; 2015 Apr; 62(4):B5057. PubMed ID: 25872541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GLP-1 and the long-term outcome of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery in morbidly obese subjects.
    Jiménez A; Casamitjana R; Flores L; Delgado S; Lacy A; Vidal J
    Ann Surg; 2013 May; 257(5):894-9. PubMed ID: 23579541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The difference of glucostatic parameters according to the remission of diabetes after Roux-en-Y gastric bypass.
    Kim MK; Lee HC; Lee SH; Kwon HS; Baek KH; Kim EK; Lee KW; Song KH
    Diabetes Metab Res Rev; 2012 Jul; 28(5):439-46. PubMed ID: 22407971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones.
    Nannipieri M; Baldi S; Mari A; Colligiani D; Guarino D; Camastra S; Barsotti E; Berta R; Moriconi D; Bellini R; Anselmino M; Ferrannini E
    J Clin Endocrinol Metab; 2013 Nov; 98(11):4391-9. PubMed ID: 24057293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormonal changes after Roux-en Y gastric bypass for morbid obesity and the control of type-II diabetes mellitus.
    Clements RH; Gonzalez QH; Long CI; Wittert G; Laws HL
    Am Surg; 2004 Jan; 70(1):1-4; discussion 4-5. PubMed ID: 14964537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvements in glucose metabolism early after gastric bypass surgery are not explained by increases in total bile acids and fibroblast growth factor 19 concentrations.
    Jørgensen NB; Dirksen C; Bojsen-Møller KN; Kristiansen VB; Wulff BS; Rainteau D; Humbert L; Rehfeld JF; Holst JJ; Madsbad S; Clausen TR
    J Clin Endocrinol Metab; 2015 Mar; 100(3):E396-406. PubMed ID: 25536209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of endogenous GLP-1 and GIP on glucose tolerance after Roux-en-Y gastric bypass surgery.
    Svane MS; Bojsen-Møller KN; Nielsen S; Jørgensen NB; Dirksen C; Bendtsen F; Kristiansen VB; Hartmann B; Holst JJ; Madsbad S
    Am J Physiol Endocrinol Metab; 2016 Apr; 310(7):E505-14. PubMed ID: 26786780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects.
    Jacobsen SH; Olesen SC; Dirksen C; Jørgensen NB; Bojsen-Møller KN; Kielgast U; Worm D; Almdal T; Naver LS; Hvolris LE; Rehfeld JF; Wulff BS; Clausen TR; Hansen DL; Holst JJ; Madsbad S
    Obes Surg; 2012 Jul; 22(7):1084-96. PubMed ID: 22359255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relevance of beta-cell function for improved glycemic control after gastric bypass surgery.
    Blanco J; Jiménez A; Casamitjana R; Flores L; Lacy A; Conget I; Vidal J
    Surg Obes Relat Dis; 2014; 10(1):9-13; quiz 189-90. PubMed ID: 24342036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced fasting and post-prandial plasma bile acid responses after Roux-en-Y gastric bypass surgery.
    Werling M; Vincent RP; Cross GF; Marschall HU; Fändriks L; Lönroth H; Taylor DR; Alaghband-Zadeh J; Olbers T; Le Roux CW
    Scand J Gastroenterol; 2013 Nov; 48(11):1257-64. PubMed ID: 24044585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roux-en-Y gastric bypass compared with equivalent diet restriction: Mechanistic insights into diabetes remission.
    Pop LM; Mari A; Zhao TJ; Mitchell L; Burgess S; Li X; Adams-Huet B; Lingvay I
    Diabetes Obes Metab; 2018 Jul; 20(7):1710-1721. PubMed ID: 29532631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The enteroinsular axis and the recovery from type 2 diabetes after bariatric surgery.
    Patriti A; Facchiano E; Sanna A; Gullà N; Donini A
    Obes Surg; 2004; 14(6):840-8. PubMed ID: 15318993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta and alpha cell function in metabolically healthy but obese subjects: relationship with entero-insular axis.
    Calanna S; Piro S; Di Pino A; Maria Zagami R; Urbano F; Purrello F; Maria Rabuazzo A
    Obesity (Silver Spring); 2013 Feb; 21(2):320-5. PubMed ID: 23404781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric bypass in the pig increases GIP levels and decreases active GLP-1 levels.
    Lindqvist A; Ekelund M; Pierzynowski S; Groop L; Hedenbro J; Wierup N
    Peptides; 2017 Apr; 90():78-82. PubMed ID: 28242256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of transoral gastroplasty on glucose homeostasis in obese subjects.
    Leccesi L; Panunzi S; De Gaetano A; Familiari P; Iaconelli A; Guidone C; Mazzarella A; Costamagna G; Mingrone G
    J Clin Endocrinol Metab; 2013 May; 98(5):1901-10. PubMed ID: 23543657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Entero-endocrine changes after gastric bypass in diabetic and nondiabetic patients: a preliminary study.
    Whitson BA; Leslie DB; Kellogg TA; Maddaus MA; Buchwald H; Billington CJ; Ikramuddin S
    J Surg Res; 2007 Jul; 141(1):31-9. PubMed ID: 17574036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Manipulating Circulating Bile Acid Concentrations on Postprandial GLP-1 Secretion and Glucose Metabolism After Roux-en-Y Gastric Bypass.
    Jonsson I; Bojsen-Møller KN; Kristiansen VB; Veedfald S; Wewer Albrechtsen NJ; Clausen TR; Kuhre RE; Rehfeld JF; Holst JJ; Madsbad S; Svane MS
    Front Endocrinol (Lausanne); 2021; 12():681116. PubMed ID: 34084153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GK-rats respond to gastric bypass surgery with improved glycemia despite unaffected insulin secretion and beta cell mass.
    Miskelly MG; Shcherbina L; Thorén Fischer AH; Abels M; Lindqvist A; Wierup N
    Peptides; 2021 Feb; 136():170445. PubMed ID: 33197511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duodenal-jejunal bypass protects GK rats from {beta}-cell loss and aggravation of hyperglycemia and increases enteroendocrine cells coexpressing GIP and GLP-1.
    Speck M; Cho YM; Asadi A; Rubino F; Kieffer TJ
    Am J Physiol Endocrinol Metab; 2011 May; 300(5):E923-32. PubMed ID: 21304061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.